Systematic Financial Management LP Decreases Stock Holdings in Sabra Healthcare REIT, Inc. $SBRA

Key Points

• Systematic Financial Management LP reduced its stake in Sabra Healthcare REIT by selling 16,294 shares, bringing its total holdings to 2,374,810 shares, which accounts for about 1.2% of its portfolio.
• Sabra Healthcare REIT reported a quarterly earnings per share (EPS) of $0.38, exceeding analysts' expectations of $0.36, with revenue increasing by 7.4% year-over-year.
• The company announced a quarterly dividend of $0.30, which will be paid on August 29th, representing a 6.1% dividend yield based on an annualized payout of $1.20.

Systematic Financial Management LP lowered its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 0.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,374,810 shares of the real estate investment trust's stock after selling 16,294 shares during the period. Sabra Healthcare REIT accounts for about 1.2% of Systematic Financial Management LP's investment portfolio, making the stock its 17th largest position. Systematic Financial Management LP owned about 1.00% of Sabra Healthcare REIT worth $41,488,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Northern Trust Corp grew its holdings in shares of Sabra Healthcare REIT by 27.7% in the fourth quarter. Northern Trust Corp now owns 4,169,385 shares of the real estate investment trust's stock valued at $72,214,000 after purchasing an additional 905,466 shares in the last quarter. Bank of New York Mellon Corp grew its stake in shares of Sabra Healthcare REIT by 1.8% in the 1st quarter. Bank of New York Mellon Corp now owns 4,114,215 shares of the real estate investment trust's stock worth $71,875,000 after buying an additional 74,564 shares in the last quarter. Nuveen LLC purchased a new position in Sabra Healthcare REIT during the first quarter worth $61,791,000. Janus Henderson Group PLC boosted its stake in Sabra Healthcare REIT by 23.1% during the fourth quarter. Janus Henderson Group PLC now owns 3,504,809 shares of the real estate investment trust's stock worth $60,720,000 after buying an additional 657,950 shares during the period. Finally, Nuveen Asset Management LLC boosted its stake in Sabra Healthcare REIT by 30.8% during the fourth quarter. Nuveen Asset Management LLC now owns 3,378,733 shares of the real estate investment trust's stock worth $58,520,000 after buying an additional 795,902 shares during the period. Institutional investors own 99.40% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Wells Fargo & Company boosted their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a research note on Wednesday. Scotiabank upped their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a report on Monday, June 23rd. JMP Securities upped their price target on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a research report on Wednesday, August 6th. Finally, BMO Capital Markets upped their price target on Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a "market perform" rating in a research report on Monday. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $20.43.

Sabra Healthcare REIT Price Performance

Shares of SBRA stock traded down $0.46 during mid-day trading on Thursday, hitting $19.16. 1,258,605 shares of the stock were exchanged, compared to its average volume of 2,453,342. The firm has a fifty day moving average of $18.52 and a 200 day moving average of $17.74. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91. Sabra Healthcare REIT, Inc. has a 52-week low of $15.60 and a 52-week high of $20.03. The company has a market cap of $4.59 billion, a PE ratio of 25.19, a price-to-earnings-growth ratio of 1.53 and a beta of 0.86.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last posted its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.02. The business had revenue of $189.15 million for the quarter, compared to analyst estimates of $185.64 million. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The company's revenue for the quarter was up 7.4% on a year-over-year basis. During the same period in the prior year, the company posted $0.36 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Research analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, August 29th. Investors of record on Friday, August 15th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 6.3%. Sabra Healthcare REIT's dividend payout ratio (DPR) is currently 157.89%.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.